UK markets closed

China Shineway Pharmaceutical Group Limited (CSWYY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
24.320.00 (0.00%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,516,538
4,516,538
3,950,636
3,223,550
2,655,701
Cost of revenue
1,122,419
1,122,419
1,012,322
813,214
667,855
Gross profit
3,394,119
3,394,119
2,938,314
2,410,336
1,987,846
Operating expenses
Research development
110,462
110,462
117,454
112,711
99,705
Selling general and administrative
2,308,122
2,308,122
2,098,456
1,756,239
1,458,828
Total operating expenses
2,418,584
2,418,584
2,215,910
1,868,950
1,558,533
Operating income or loss
975,535
975,535
722,404
541,386
429,313
Interest expense
2,737
2,737
630
1,254
16,600
Income before tax
1,240,253
1,240,253
917,025
720,103
395,024
Income tax expense
270,743
270,743
194,252
163,429
99,991
Income from continuing operations
969,510
969,510
722,773
556,674
295,033
Net income
969,510
969,510
722,773
556,674
295,033
Net income available to common shareholders
969,510
969,510
722,773
556,674
295,033
Basic EPS
23.40
-
19.20
14.80
7.80
Diluted EPS
23.40
-
19.20
14.80
7.80
Basic average shares
37,770
-
37,770
37,757
37,825
Diluted average shares
37,770
-
37,770
37,757
37,837